[go: up one dir, main page]

WO2009066309A9 - Procédé de préparation d'oméprazole - Google Patents

Procédé de préparation d'oméprazole Download PDF

Info

Publication number
WO2009066309A9
WO2009066309A9 PCT/IN2008/000445 IN2008000445W WO2009066309A9 WO 2009066309 A9 WO2009066309 A9 WO 2009066309A9 IN 2008000445 W IN2008000445 W IN 2008000445W WO 2009066309 A9 WO2009066309 A9 WO 2009066309A9
Authority
WO
WIPO (PCT)
Prior art keywords
omeprazole
preparation
pyridinyl
methyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000445
Other languages
English (en)
Other versions
WO2009066309A2 (fr
WO2009066309A3 (fr
Inventor
Dhimant Jasubhai Patel
Mahesh Shankarbhai Patel
Shriprakash Dhar Dwivedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zydus Lifesciences Ltd
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of WO2009066309A2 publication Critical patent/WO2009066309A2/fr
Publication of WO2009066309A3 publication Critical patent/WO2009066309A3/fr
Anticipated expiration legal-status Critical
Publication of WO2009066309A9 publication Critical patent/WO2009066309A9/fr
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé permettant de préparer des benzimidazoles à substitution 2-[(pyridinyl)méthyl]sulfinyle, représentés par la formule (I) ou un sel, hydrate, ou solvate pharmaceutiquement acceptable de ces composés. Plus particulièrement, la présente invention concerne le procédé d'oxydation de benzimidazoles à substitution 2-[(pyridinyl)méthyl]thio, représentés par la formule (II).
PCT/IN2008/000445 2007-07-12 2008-07-11 Procédé de préparation d'oméprazole Ceased WO2009066309A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1335MU2007 2007-07-12
IN1335/MUM/2007 2007-07-12

Publications (3)

Publication Number Publication Date
WO2009066309A2 WO2009066309A2 (fr) 2009-05-28
WO2009066309A3 WO2009066309A3 (fr) 2010-01-07
WO2009066309A9 true WO2009066309A9 (fr) 2010-05-14

Family

ID=40667935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000445 Ceased WO2009066309A2 (fr) 2007-07-12 2008-07-11 Procédé de préparation d'oméprazole

Country Status (1)

Country Link
WO (1) WO2009066309A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4053125B1 (fr) * 2019-10-31 2024-12-04 Kumiai Chemical Industry Co., Ltd. Procédé pour la production d'un herbicide pyroxasulfone
CN112229920B (zh) * 2020-09-17 2022-10-21 海南中玉药业有限公司 一种艾司奥美拉唑钠潜在基因毒性杂质的检测方法
CN115785067A (zh) * 2023-01-19 2023-03-14 北京京卫燕康药物研究所有限公司 一种艾司奥美拉唑硫醚的杂质化合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
AT408546B (de) * 1999-04-13 2001-12-27 Dsm Fine Chem Austria Gmbh Singlet sauerstoff oxidation von organischen substraten
GB9921578D0 (en) * 1999-09-13 1999-11-17 Cipla Limited Omeprazole synthesis
ES2163372B1 (es) * 2000-03-13 2003-05-01 Esteve Quimica Sa Procedimiento de oxidacion de un grupo tioeter a sulfoxido.
ES2441970T3 (es) * 2004-09-13 2014-02-07 Takeda Pharmaceutical Company Limited Método para producir lansoprazol
TW200619198A (en) * 2004-12-10 2006-06-16 Ind Tech Res Inst Method for preparing 2-(2-pyridylmethylsulphinyl)benzimidazoles
EP2030973A1 (fr) * 2007-08-31 2009-03-04 KRKA, tovarna zdravil, d.d., Novo mesto Procédé pour la préparation de 2-sulfinyl-1H-benzimidazoles

Also Published As

Publication number Publication date
WO2009066309A2 (fr) 2009-05-28
WO2009066309A3 (fr) 2010-01-07

Similar Documents

Publication Publication Date Title
FIC20220043I1 (fi) Difelikefaliini, valinnaisesti farmaseuttisesti hyväksyttävänä suolana, hydraattina, solvaattina, happosuolahydraattina tai N-oksidina
ZA200906050B (en) Process for the preparation of a benzimidazole derivative
IL198330A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
IL192242A0 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
WO2009066326A3 (fr) Procédé amélioré pour la préparation de prasugrel et de ses sels pharmaceutiquement acceptables
IL198847A0 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL198388A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
WO2008045777A3 (fr) Procédé pour la préparation de dérivés de benzimidazole, et de leurs sels
WO2008058118A3 (fr) Préparation de montélukast et de ses sels
WO2010056644A8 (fr) 1-(arylsulfonyl)-4-(pipérazin-1-yl)-1h-benzimidazoles en tant que ligands de δ-hydroxytriptamine-6
SI2176229T1 (sl) Nove kristalne oblike 3-(difluormetil)-1-metil-n-(3',4',5'-trifluor(1,1'-bifenil)-2-il)-1h- pirazol-4-karboksamida
WO2009074247A8 (fr) Nouveaux dérivés d'amide d'acide 2-arylthiazole-4-carboxylique, leur préparation et leur utilisation en tant que médicament
WO2010123545A3 (fr) Inhibiteurs de l'angiogenèse
TNSN08369A1 (en) Benzimidazole derivatives
WO2009097515A3 (fr) Composés d'indole fondus-[a], leur utilisation en tant qu'inhibiteurs de mtor kinase et de pi3 kinase, et leurs synthèses
ZA201007649B (en) 7h-indolo[2,1-a][2]benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
GB2436262B (en) Process for the preparation of pantoprazole sodium
WO2008009970A3 (fr) Procédé
WO2008049922A3 (fr) Nouveau procédé de préparation du montélukast
EP2024369A4 (fr) Nouveau procédé de préparation du citrate de sildénafil
WO2009066309A3 (fr) Procédé de préparation d'oméprazole
WO2009075516A3 (fr) Procédé de préparation de pantoprazole sodique sesquihydrate
IL186294A0 (en) A process for the preparation of phenyltetrazole compounds
WO2009116072A3 (fr) Procédé de préparation de composés de pyridinylméthylsulphinyl benzimidazole et intermédiaires de pyridine
WO2008015530A3 (fr) Formulation orale solide stable d'un medicament acide labile

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08852115

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08852115

Country of ref document: EP

Kind code of ref document: A2